- January sales figures showed a 12 per cent increase over the prior month and a 30% increase year over year
- Fiore’s brand portfolio and products include: Fiore Cannabis, Diamante Labs, PureCloud 9, Surfer and The Weekender
- The additional products can be expected to begin generating sales as early as the second quarter of 2021
- Fiore Cannabis (FIOR) has been investing in the development of medical and recreational cannabis products since 2014
- Fiore Cannabis (FIOR) opened trading at C$0.115 per share
Fiore Cannabis (FIOR) announced the expanded portfolio of cannabis products from its Apex Cultivation and Production Facility in Las Vegas, Nevada.
Fiore’s brand portfolio and products include: Fiore Cannabis, Diamante Labs (extracts), PureCloud 9 (skincare), Surfer and The Weekender.
The additional products can be expected to begin generating sales as early as the second quarter of 2021.
“The company has successfully been cultivating and producing Fiore-branded organic flower and recently added Diamante-branded extracts. With U.S. markets like Nevada beginning to see sizable increases in demand as COVID-19 restrictions continue to improve, we saw an opportunity to launch a broader portfolio of products. Our decision has also been spurred on by the strong retail sales performance in Nevada as January sales figures showed a 12% increase over the prior month and a 30% increase year over year,” said Erik Anderson, President and CEO of Fiore Cannabis.
“We’re excited to share the full product portfolio with the market now that Nevada and specifically Las Vegas’s tourism sector are returning to fuller economic health. We have been developing fresh and innovative cannabis brands such as Surfer and The Weekender so seeing them flow into the market is going to be great for Fiore and for the Company’s overall sales potential. Our products are aimed at discerning cannabis connoisseurs and have been tailored specifically to the local market so we can expect strong demand and quality margins on these products,” said Anderson.
Fiore Cannabis is a publicly-traded company that has been investing in the development of medical and recreational cannabis products since 2014.
Fiore Cannabis (FIOR) opened trading at C$0.115 per share.
